nisoldipine has been researched along with Coronary Artery Disease in 3 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Fifteen male patients with stable angina pectoris treated with atenolol were studied after undergoing routine cardiac catheterisation." | 9.07 | A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease. ( Dawkins, KD; Donaldson, KM; Waller, DG, 1993) |
| "The NICOLE study (NIsoldipine in COronary artery disease in LEuven) is a single centre, randomised, double blind, placebo controlled trial with coronary angiography at baseline, six months, and three years of follow up." | 5.10 | Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study. ( Coussement, P; De Scheerder, IK; Dens, JA; Desmet, WJ; Kerdsinchai, P; Kostopoulos, K; Piessens, JH; Supanantaroek, C, 2003) |
| " Fifteen male patients with stable angina pectoris treated with atenolol were studied after undergoing routine cardiac catheterisation." | 5.07 | A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease. ( Dawkins, KD; Donaldson, KM; Waller, DG, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dens, JA | 1 |
| Desmet, WJ | 1 |
| Coussement, P | 1 |
| De Scheerder, IK | 1 |
| Kostopoulos, K | 1 |
| Kerdsinchai, P | 1 |
| Supanantaroek, C | 1 |
| Piessens, JH | 1 |
| Donaldson, KM | 1 |
| Dawkins, KD | 1 |
| Waller, DG | 1 |
| Nayler, WG | 1 |
2 trials available for nisoldipine and Coronary Artery Disease
| Article | Year |
|---|---|
Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study.
Topics: Calcium Channel Blockers; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Disease | 2003 |
A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Calcium Channel | 1993 |
1 other study available for nisoldipine and Coronary Artery Disease
| Article | Year |
|---|---|
Therapeutic approaches to the control of coronary atherosclerosis.
Topics: Animals; Aorta; Calcium; Cholesterol; Cholesterol, Dietary; Coronary Artery Disease; Diet, Atherogen | 1994 |